More on CVS Caremark's Q4

|About: CVS Health Corporation (CVS)|By:, SA News Editor

CVS Caremark (CVS) saw broad sales growth in Q4, with Pharmacy Services revenue up 5.2% and Retail Pharmacy sales growth of 5.6%.

Retail Pharmacy Segment same store sales rose 4.0% during the period.

Gross profit rate fell 60 bps to 30.7%.

The company expects 2014 EPS of $4.36-$4.50 vs. $4.47 consensus.

A conference call is scheduled for 8:30 am where more details on the company's exit from tobacco could be discussed. (webcast)

CVS +0.7% premarket